cox 189 has been researched along with terutroban in 1 studies
| Studies (cox 189) | Trials (cox 189) | Recent Studies (post-2010) (cox 189) | Studies (terutroban) | Trials (terutroban) | Recent Studies (post-2010) (terutroban) |
|---|---|---|---|---|---|
| 163 | 49 | 47 | 61 | 13 | 24 |
| Protein | Taxonomy | cox 189 (IC50) | terutroban (IC50) |
|---|---|---|---|
| Thromboxane A2 receptor | Homo sapiens (human) | 0.0164 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertinaria, M; Buccellati, C; Capra, V; Carnevali, S; Cena, C; Fruttero, R; Garella, D; Hoxha, M; Rolando, B; Rovati, GE; Sala, A | 1 |
1 other study(ies) available for cox 189 and terutroban
| Article | Year |
|---|---|
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Female; HEK293 Cells; Humans; Male; Middle Aged; Naphthalenes; Naproxen; Propionates; Receptors, Thromboxane; Young Adult | 2016 |